Completed PHASE4 INTERVENTIONAL 2-arm NCT02524652

Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction

Postoperative Analgesic Efficacy of Local Infiltration Analgesia Versus Adductor Canal Block After Anterior Cruciate Ligament Reconstruction: A Randomised Controlled Double-blinded Trial

Sponsor: Centre Hospitalier Universitaire Vaudois

Conditions Infiltration Regional Anesthesia Morbidity Rupture of Anterior Cruciate Ligament

Interventions Ropivacaine 0.5% 20 mLs

Updated 5 times since 2017 Last updated: May 4, 2018 Started: Sep 30, 2015 Primary completion: Mar 31, 2018 Completion: Mar 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02524652, this PHASE4 trial focuses on Infiltration and Regional Anesthesia Morbidity and remains completed. Sponsored by Centre Hospitalier Universitaire Vaudois, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire Vaudois

Data source: Centre Hospitalier Universitaire Vaudois

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lausanne, Switzerland